Direct regulatory role of NKT cells in allogeneic graft survival is dependent on the quantitative strength of antigenicity

Journal of Immunology

Volumn 174, Issue 4, 2005, Pages 2030-2036

  Oh, Keunhee ^a,b,f   Kim, Sanghee ^b,f   Park, Se Ho ^c   Gu, Hua ^d   Roopenian, Derry ^e   Doo, Hyun Chung ^b   Yon, Su Kim ^b   Lee, Dong Sup ^a,b,f  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Korea University   (South Korea)

^d NewYork Presbyterian Hospital   (United States)

^e JACKSON LABORATORY   (United States)

^f Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; ALPHA GALATOSYLCERAMIDE; ANTIGEN; CD1D ANTIGEN; CERAMIDE DERIVATIVE; INTERLEUKIN 10; UNCLASSIFIED DRUG;

ALLOGRAFT; ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGENICITY; ARTICLE; CELL ACTIVATION; CELL MIGRATION; CONTROLLED STUDY; FEMALE; HISTOCOMPATIBILITY; ISOGRAFT; MALE; MONONUCLEAR CELL; MOUSE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SKIN GRAFT; SPLEEN CELL; T LYMPHOCYTE;

EID: 13544262688     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.4.2030     Document Type: Article

References (43)

1. Yoshimoto, T., and W. E. Paul. 1994. CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179:1285.
2. Bendelac, A., M. N. Rivera, S. H. Park, and J. H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535.
3. Porcelli, S. A., and R. L. Modlin. 1999. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 17:297.
4. Godfrey, D. I., K. J. Hammond, L. D. Poulton, M. J. Smyth, and A. G. Baxter. 2000. NKT cells: facts, functions and fallacies. Immunol. Today 21:573.
5. Kronenberg, M., and L. Gapin. 2002. The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2:557.
6. Singh, A. K., M. T. Wilson, S. Hong, D. Olivares-Villagomez, C. Du, A. K. Stanic, S. Joyce, S. Sriram, Y. Koezuka, and L. Van Kaer. 2001. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J. Exp. Med. 194:1801.
7. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 278:1623.
8. Smyth, M. J., K. Y. Thia, S. E. Street, E. Cretney, J. A. Trapani, M. Taniguchi, T. Kawano, S. B. Pelikan, N. Y. Crowe, and D. I. Godfrey. 2000. Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med. 191:661.
9. Kakimi, K., L. G. Guidotti, Y. Koezuka, and F. V. Chisari. 2000. Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192:921.
10. Taniguchi, M., K. Seino, and T. Nakayama. 2003. The NKT cell system: bridging innate and acquired immunity. Nat. Immunol. 4:1164.
11. + NK T cells associated with disease development in autoimmune-prone mice. J. Immunol. 156:4035.
12. Shi, F. D., M. Flodstrom, B. Balasa, S. H. Kim, K. Van Gunst, J. L. Strominger, S. B. Wilson, and N. Sarvetnick. 2001. Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse. Proc. Natl. Acad. Sci. USA 98:6777.
13. Hong, S., M. T. Wilson, I. Serizawa, L. Wu, N. Singh, O. V. Naidenko, T. Miura, T. Haba, D. C. Scherer, J. Wei, et al. 2001. The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat. Med. 7:1052.
14. Sharif, S., and T. L. Delovitch. 2001. Regulation of immune responses by natural killer T cells. Arch. Immunol. Ther. Exp. 49(Suppl. 1):S23.
15. + Vα4 natural killer T cells are essential for acceptance of rat islet xenografts in mice. J. Clin. Invest. 105:1761.
16. Seino, K. I., K. Fukao, K. Muramoto, K. Yanagisawa, Y. Takada, S. Kakuta, Y. Iwakura, L. Van Kaer, K. Takeda, T. Nakayama, et al. 2001. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc. Natl. Acad. Sci. USA 98:2577.
17. Sonoda, K. H., and J. Stein-Streilein. 2002. CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance. Eur. J. Immunol. 32:848.
18. Faunce, D. E., K. H. Sonoda, and J. Stein-Streilein. 2001. MIP-2 recruits NKT cells to the spleen during tolerance induction. J. Immunol. 166:313.
19. + T cells to the spleen during the generation of regulatory T cells in tolerance. J. Immunol. 169:31.
20. Graca, L., S. P. Cobbold, and H. Waldmann. 2002. Identification of regulatory T cells in tolerated allografts. J. Exp. Med. 195:1641.
21. Sanchez-Fueyo, A., M. Weber, C. Domenig, T. B. Strom, and X. X. Zheng. 2002. Tracking the immunoregulatory mechanisms active during allograft tolerance. J. Immunol. 168:2274.
22. + T cells. Immunity 7:209.
23. Lee, D. S., C. Ahn, B. Ernst, J. Sprent, and C. D. Surh. 1999. Thymic selection by a single MHC/peptide ligand: autoreactive T cells are low-affinity cells. Immunity 10:83.
24. Kim, S., S. Song, T. Lee, S. Jung, and D. Kim. 2004. Practical synthesis of KRN7000 from phytosphingosine. Synthesis 847.
25. Rugo, H. S., P. O'Hanley, A. G. Bishop, M. K. Pearce, J. S. Abrams, M. Howard, and A. O'Garra. 1992. Local cytokine production in a murine model of Escherichia coli pyelonephritis. J. Clin. Invest. 89:1032.
26. O'Garra, A., and M. Howard. 1992. IL-10 production by CD5 B cells. Ann. NY Acad. Sci. 651:182.
27. Xia, D., A. Sanders, M. Shah, A. Bickerstaff, and C. Orosz. 2001. Real-time polymerase chain reaction analysis reveals an evolution of cytokine mRNA production in allograft acceptor mice. Transplantation 72:907.
28. Simpson, E., A. McLaren, and P. Chandler. 1982. Evidence for two male antigens in mice. Immunogenetics 15:609.
29. Choi, E. Y., Y. Yoshimura, G. J. Christianson, T. J. Sproule, S. Malarkannan, N. Shastri, S. Joyce, and D. C. Roopenian. 2001. Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: the H60 histocompatibility antigen dominates over all others. J. Immunol. 166:4370.
30. - T cells in mice and humans. J. Exp. Med. 180:1097.
31. + T cell populations. Int. Immunol. 7:1157.
32. Sonoda, K. H., M. Exley, S. Snapper, S. P. Balk, and J. Stein-Streilein. 1999. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site. J. Exp. Med. 190:1215.
33. Jones, N. D., S. E. Turvey, A. Van Maurik, M. Hara, C. I. Kingsley, C. H. Smith, A. L. Mellor, P. J. Morris, and K. J. Wood. 2001. Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. J. Immunol. 166:2824.
34. Sonoda, K.-H., M. Taniguchi, and J. Stein-Streilein. 2002. Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells. J. Immunol. 168:2028.
35. Cavani, A., O. C., F. Nasorri, S. Sebastiani, and G. Girolomoni. 2003. Immunoregulation of hapten and drug induced immune reactions. Curr. Opin. Allergy Clin. Immunol. 3:243.
36. Seong, S. Y., and P. Matzinger. 2004. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 4:469.
37. Brossay, L., M. Chioda, N. Burdin, Y. Koezuka, G. Casorati, P. Dellabona, and M. Kronenberg. 1998. CD1d-mediated recognition of an α- galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J. Exp. Med. 188:1521.
38. Park, S. H., J. H. Roark, and A. Bendelac. 1998. Tissue-specific recognition of mouse CD1 molecules. J. Immunol. 160:3128.
39. Thomas, S. Y., R. Hou, J. E. Boyson, T. K. Means, C. Hess, D. P. Olson, J. L. Strominger, M. B. Brenner, J. E. Gumperz, S. B. Wilson, and A. D. Luster. 2003. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J. Immunol. 171:2571.
40. Jonuleit, H., and E. Schmitt. 2003. The regulatory T cell family: distinct subsets and their interrelations. J. Immunol. 171:6323.
41. Prud'homme, G. J., D. H. Kono, and A. N. Theofilopoulos. 1995. Quantitative polymerase chain reaction analysis reveals marked overexpression of interleukin-1β, interleukin-1 and interferon-γ mRNA in the lymph nodes of lupus-prone mice. Mol. Immunol. 32:495.
42. + T cells produce large amounts of IL-4 and IFN-γ upon activation by anti-CD3 or CD1. J. Immunol. 159:2240.
43. Beebe, A. M., S. Mauze, N. J. Schork, and R. L. Coffman. 1997. Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice. Immunity 6:551.